Target intelligence / Profile preview

RNF207 antisense RNA 1 (RNF207-AS1)

Target
RNF207-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other (per classification, not a protein-coding gene, not a receptor, not an enzyme)
01

Overview

RNF207 antisense RNA 1 (RNF207-AS1) is a long non-coding antisense transcript expressed from the RNF207 locus. Antisense RNAs can regulate gene expression at various biological levels, including transcription, mRNA stability, and translation, often by interacting with their sense gene counterparts through complementary base pairing or transcriptional interference. Although general functions for antisense lncRNAs include modulation of gene expression and chromatin remodeling, there is insufficient evidence to attribute specific biological roles or therapeutic relevance to RNF207-AS1 itself. Its sense gene, RNF207, is a RING finger domain-containing protein with established roles in cardiac electrophysiology and regulation of potassium channels, but these functions do not extend directly to the antisense RNA. RNF207-AS1 has no documented clinical relevance as a drug target, biomarker, or safety concern at this time.

02

Mechanism of action

Not applicable for drugs, since no drugs are known to act on RNF207-AS1 directly

03

Biological functions

Regulation of gene expression (possible modulation via antisense mechanisms, but specific functions for RNF207-AS1 are not described in current databases or literature)Other (the role of antisense RNAs may include transcriptional interference, mRNA stability, and epigenetic regulation)
04

Disease associations

Other (No specific diseases linked to RNF207-AS1. Some antisense lncRNAs are implicated in cancer, but RNF207-AS1 has not been directly implicated; its sense gene RNF207 is associated with cardiac function and QT interval regulation)Indirect relationship possible via the influence on RNF207, which is associated with cardiac electrophysiology and QT interval

Beyond the preview

Go deeper on RNF207 antisense RNA 1 (RNF207-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNF207 antisense RNA 1 (RNF207-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call